Elsevier Ltd

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Derkach
    Derkach
  3. Epstein-Peterson
    Epstein-Peterson
  4. Devlin
    Devlin
  5. Goldberg
    Goldberg
  6. Stein
    Stein
  7. Famulare
    Famulare
  8. Levine
    Levine
  9. Arango Ossa
    Arango Ossa
  10. Dewolf
    Dewolf

Groups

  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Hematologic Malignancies, Division of (11)
  4. Hematology-Oncology Fellows (11)
  5. Weinberg Fellows (11)
  6. Adult Leukemia (10)
  7. Biostatistics Service (7)
  8. Epidemiology and Biostatistics (7)
  9. Population Sciences Research Program (5)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (2)
Search Within
  1. "Weinberg Fellows"
Formats
  1. Journal Article (10)
  2. Review (1)
Groups
  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Hematologic Malignancies, Division of (11)
  4. Hematology-Oncology Fellows (11)
  5. Weinberg Fellows (11)
  6. Adult Leukemia (10)

More Groups

People
  1. Martin Tallman (8)
  2. Andriy Derkach (4)
  3. Zachary Epstein-Peterson (4)
  4. Aaron Goldberg (3)
  5. Eytan Stein (3)
  6. Sean Devlin (3)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (3)
  6. 2019 (2)

More Years

Publications
  1. Leukemia Research (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • New treatments for adult T-cell leukemia/lymphoma
    Review

    Epstein-Peterson, Z. D.; Gurumurthi, A.; Horwitz, S. M.
    Leukemia Research (2025)

    Fulltext@MSK | Save
  • Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
    Journal Article

    Atchley, E.; Weis, T. M.; Derkach, A.; Galera, P. K.; Xiao, W.; Glass, J.; DeWolf, S.; Roshal, M.; Shah, R.; Stump, S. E.
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features
    Journal Article

    Epstein-Peterson, Z. D.; Spitzer, B.; Derkach, A.; Arango, J. E.; McCarter, J. G. W.; Medina-Martínez, J. S.; McGovern, E.; Farnoud, N. R.; Levine, R. L.; Tallman, M. S.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy
    Journal Article

    Glass, J. L.; Derkach, A.; Hilden, P.; King, A.; Seo, S. K.; Ahr, K.; Kishtagari, A.; Levine, R. L.; Tallman, M. S.; Douer, D.
    Leukemia Research (2021)

    Fulltext@MSK | Save
  • Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes
    Journal Article

    Menghrajani, K.; Zhang, Y.; Famulare, C.; Devlin, S. M.; Tallman, M. S.
    Leukemia Research (2020)

    Fulltext@MSK | Save
  • Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
    Journal Article

    Goldberg, A. D.; Atallah, E.; Rizzieri, D.; Walter, R. B.; Chung, K. Y.; Spira, A.; Stock, W.; Tallman, M. S.; Cruz, H. G.; Boni, J.; more...
    Leukemia Research (2020)

    Fulltext@MSK | Save
  • Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy
    Journal Article

    Talati, C.; Goldberg, A. D.; Przespolewski, A.; Chan, O.; Ali, N. A.; Kim, J.; Famulare, C.; Sallman, D.; Padron, E.; Kuykendall, A.; more...
    Leukemia Research (2020)

    Fulltext@MSK | Save
  • Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer
    Journal Article

    Epstein-Peterson, Z. D.; Devlin, S. M.; Stein, E. M.; Klimek, V. M.; Saltz, L. B.; Tallman, M. S.
    Leukemia Research (2019)

    Fulltext@MSK | Save
  • Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
    Journal Article

    King, A. C.; Pappacena, J. J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
    Leukemia Research (2019)

    Fulltext@MSK | Save

    • Elsevier Ltd – authorized name for: